First, we examined metalloproteinase-2 (MMP-2) and metalloproteinase-9 (MMP-9), key proteolytic enzymes involved in the degradation of the basement membrane and extracellular matrix [46] whose overexpression has been recently correlated with poor survival outcome in CRC patients [47]. The gene discussed is MMP9; the disease is colorectal carcinoma.